Kovitz Investment Group Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Kovitz Investment Group Partners's EW Position: Q1 2026 in Review
Kovitz Investment Group Partners reduced its Edwards Lifesciences (EW) stake by 49% in Q1 2026, selling an estimated $610K and leaving 7,581 shares worth $607K. The position accounts for 0.01% of the portfolio, ranked #375.
Kovitz Investment Group Partners first reported a position in EW in Q2 2021 and has held it in 17 quarters since. The position peaked at $5.36M in Q2 2022. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Kovitz Investment Group Partners held 7,581 shares of Edwards Lifesciences worth $607K as of Q1 2026.
- Kovitz Investment Group Partners sold 7,404 Edwards Lifesciences shares in Q1 2026, an estimated $610K.
- Edwards Lifesciences made up 0.01% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #375 holding.
- Kovitz Investment Group Partners first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 17 quarters since.
- Kovitz Investment Group Partners's Edwards Lifesciences position peaked at $5.36M in Q2 2022.
- 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.